Orsay, France

François Moreau

This inventor holds 1 USPTO granted patent and 7 published patent applications and 2 EPO patents. Top assignee: Laboratoire Biodim. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Moreau. Retrieved from https://idiyas.com/inventor/françois-moreau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: François Moreau: Innovator in Antibacterial Compounds

Introduction

François Moreau is a notable inventor based in Orsay, France. He has made significant contributions to the field of antibacterial research, particularly through his innovative work on Imidazolo-heteroaryl derivatives.

Latest Patents

Moreau holds a patent for Imidazolo-heteroaryl derivatives with antibacterial properties. This invention relates to compounds that inhibit the activity of the Dlta enzyme in Gram-positive bacteria. These compounds are particularly useful for treating Gram-positive bacterial infections. The patent also discloses methods for assessing the Dlta inhibitory activity of tested molecules and measuring the efficacy of these molecules in inhibiting bacterial proliferation in vitro. He has 1 patent to his name.

Career Highlights

Throughout his career, François Moreau has worked with various organizations, including Laboratoire Biodim and Mutabilis. His work has focused on developing new compounds that can combat bacterial infections effectively.

Collaborations

Moreau has collaborated with notable colleagues such as Sonia Escaich and Alexis Denis, contributing to the advancement of antibacterial research.

Conclusion

François Moreau's innovative work in the field of antibacterial compounds highlights his commitment to addressing significant health challenges. His contributions continue to impact the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…